Korzenik JR - Search Results

1

Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists.

Hait EJ, Barendse RM, Arnold JH, Valim C, Sands BE, Korzenik JR, Fishman LN. Hait EJ, et al. Among authors: korzenik jr. J Pediatr Gastroenterol Nutr. 2009 Jan;48(1):61-5. doi: 10.1097/MPG.0b013e31816d71d8. J Pediatr Gastroenterol Nutr. 2009. PMID: 19172125

2

Small Cells, Big Problems: Small Cell Carcinoma of the Rectal Cuff After Ileal-Pouch Anal Anastomosis in a Patient with Ulcerative Colitis.

Dalal RS, Baranov E, Li J, Hong X, Korzenik J, Hamilton M, Sasson G. Dalal RS, et al. Dig Dis Sci. 2023 Nov;68(11):4127-4129. doi: 10.1007/s10620-023-08110-0. Epub 2023 Sep 22. Dig Dis Sci. 2023. PMID: 37740133 No abstract available.

3

Infliximab maintenance therapy for fistulizing Crohn's disease.

Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Sands BE, et al. Among authors: korzenik jr. N Engl J Med. 2004 Feb 26;350(9):876-85. doi: 10.1056/NEJMoa030815. N Engl J Med. 2004. PMID: 14985485 Free article. Clinical Trial.

4

Evolving knowledge and therapy of inflammatory bowel disease.

Korzenik JR, Podolsky DK. Korzenik JR, et al. Nat Rev Drug Discov. 2006 Mar;5(3):197-209. doi: 10.1038/nrd1986. Nat Rev Drug Discov. 2006. PMID: 16518373 Review.

5

Risks and benefits of infliximab for the treatment of Crohn's disease.

Siegel CA, Hur C, Korzenik JR, Gazelle GS, Sands BE. Siegel CA, et al. Among authors: korzenik jr. Clin Gastroenterol Hepatol. 2006 Aug;4(8):1017-24; quiz 976. doi: 10.1016/j.cgh.2006.05.020. Epub 2006 Jul 14. Clin Gastroenterol Hepatol. 2006. PMID: 16843733

6

The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark.

Kaplan GG, Pedersen BV, Andersson RE, Sands BE, Korzenik J, Frisch M. Kaplan GG, et al. Gut. 2007 Oct;56(10):1387-92. doi: 10.1136/gut.2007.121467. Epub 2007 May 9. Gut. 2007. PMID: 17494106 Free PMC article.

7

Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysis.

Kaplan GG, Hur C, Korzenik J, Sands BE. Kaplan GG, et al. Aliment Pharmacol Ther. 2007 Dec;26(11-12):1509-20. doi: 10.1111/j.1365-2036.2007.03548.x. Epub 2007 Oct 11. Aliment Pharmacol Ther. 2007. PMID: 17931345 Free article.

8

Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis.

Kaplan GG, McCarthy EP, Ayanian JZ, Korzenik J, Hodin R, Sands BE. Kaplan GG, et al. Gastroenterology. 2008 Mar;134(3):680-7. doi: 10.1053/j.gastro.2008.01.004. Epub 2008 Jan 10. Gastroenterology. 2008. PMID: 18242604

9

Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications.

Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L. Kunitake H, et al. J Gastrointest Surg. 2008 Oct;12(10):1730-6; discussion 1736-7. doi: 10.1007/s11605-008-0630-8. Epub 2008 Aug 16. J Gastrointest Surg. 2008. PMID: 18709514

10

The risk of developing Crohn's disease after an appendectomy: a meta-analysis.

Kaplan GG, Jackson T, Sands BE, Frisch M, Andersson RE, Korzenik J. Kaplan GG, et al. Am J Gastroenterol. 2008 Nov;103(11):2925-31. doi: 10.1111/j.1572-0241.2008.02118.x. Epub 2008 Sep 4. Am J Gastroenterol. 2008. PMID: 18775018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page